Methotrexate-loaded PLGA nanobubbles for ultrasound imaging and Synergistic Targeted therapy of residual tumor during HIFU ablation
Source abstract
Abstract
High intensity focused ultrasound (HIFU) has attracted the great attention in tumor ablation due to its non-invasive, efficient and economic features. However, HIFU ablation has its intrinsic limitations for removing the residual tumor cells, thus the tumor recurrence and metastasis cannot be avoided in this case. Herein, we developed a multifunctional targeted poly(lactic-co-glycolic acid) (PLGA) nanobubbles (NBs), which not only function as an efficient ultrasound contrast agent for tumor imaging, but also a targeted anticancer drug carrier and excellent synergistic agent for enhancing the therapeutic efficiency of HIFU ablation. Methotrexate (MTX)-loaded NBs were synthesized and filled with perfluorocarbon gas subsequently using a facile but general double emulsion evaporation method. The active tumor-targeting monoclonal anti-HLA-G antibodies (mAbHLA-G) were further conjugated onto the surface of nanobubbles. The mAbHLA-G/MTX/PLGA NBs could enhance the ultrasound imaging both in vitro and in vivo, and the targeting efficiency to HLA-G overexpressing JEG-3 cells has been demonstrated. The elaborately designed mAbHLA-G/MTX/PLGA NBs can specifically target to the tumor cells both in vitro and in vivo, and their blood circulation time in vivo was much longer than non-targeted MTX/PLGA NBs. Further therapeutic evaluations showed that the targeted NBs as a synergistic agent can significantly improve the efficiency of HIFU ablation by changing the acoustic environment, and the focused ultrasound can promote the on-demand MTX release both in vitro and in vivo. The in vivo histopathology test and immunohistochemical analysis showed that the mAbHLA-G/MTX/PLGA NBs plus HIFU group presented most serious coagulative necrosis, the lowest proliferation index and the highest apoptotic index. Therefore, the successful introduction of targeted mAbHLA-G/MTX/PLGA NBs provides an excellent platform for the highly efficient, imaging-guided and non-invasive HIFU synergistic therapy of cancer with the supplementary functions of killing residual tumor cells and preventing tumor recurrence/metastasis.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Ultrasound and Hyperthermia Applications · Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (32)
Show source-provided references
1. Tumor ablation and nanotechnology10.1021/mp1001944 ↗
2. High intensity focused ultrasound ablation: a new therapeutic option for solid tumors10.4103/0973-1482.77064 ↗
3. High-intensity focused ultrasound in the treatment of solid tumours10.1038/nrc1591 ↗
4. Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview10.1016/j.ultsonch.2004.01.011 ↗
5. Ultrasound focal beam surgery10.1016/0301-5629(95)02010-1 ↗
6. Effect of microbubble contrast agent during high intensity focused ultrasound ablation on rabbit liver in vivo10.1016/j.ejrad.2011.06.002 ↗
7. Clinical utility of a microbubble-enhancing contrast (“SonoVue”) in treatment of uterine fibroids with high intensity focused ultrasound: a retrospective study10.1016/j.ejrad.2012.04.030 ↗
8. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect10.1016/j.addr.2010.10.008 ↗
9. Synthesizing and binding dual-mode poly (lactic-co-glycolic acid) (PLGA) nanobubbles for cancer targeting and imaging10.1016/j.biomaterials.2009.11.052 ↗
10. Comparison of in vitro and in vivo acoustic response of a novel 50:50 PLGA contrast agent10.1016/j.ultras.2006.04.003 ↗
11. Superparamagnetic PLGA-iron oxide microcapsules for dual-modality US/MR imaging and high intensity focused US breast cancer ablation10.1016/j.biomaterials.2012.04.062 ↗
12. Microbubbles from gas-generating perfluorohexane nanoemulsions for targeted temperature-sensitive ultrasonography and synergistic HIFU ablation of tumors10.1002/adma.201301655 ↗
13. A critical look at HLA-G10.1016/j.it.2008.02.012 ↗
14. Nanoparticulate delivery system targeted to tumor neovasculature for combined anticancer and antiangiogenesis therapy10.1007/s11095-010-0308-2 ↗
15. Specific and non-specific phagocytosis of ligand-grafted PLGA microspheres by macrophages10.1016/j.ejps.2008.11.013 ↗
16. Lysine-tagged peptide coupling onto polylactide nanoparticles coated with activated ester-based amphiphilic copolymer: a route to highly peptide-functionalized biodegradable carriers10.1016/j.colsurfb.2012.10.032 ↗
17. Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation10.2217/17435889.2.2.219 ↗
18. Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment10.1016/j.biomaterials.2011.09.096 ↗
19. Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery10.1016/j.ijpharm.2011.05.030 ↗
20. Ultrasound triggered drug release from 10-hydroxycamptothecin-loaded phospholipid microbubbles for targeted tumor therapy in mice10.1016/j.jconrel.2012.07.009 ↗
21. A novel ultrasound microbubble carrying gene and Tat peptide: preparation and characterization10.1016/j.acra.2009.06.018 ↗
22. Hematoporphyrin encapsulated PLGA microbubble for contrast enhanced ultrasound imaging and sonodynamic therapy10.3109/02652048.2012.655333 ↗
23. Antitumor effect of docetaxel-loaded lipid microbubbles combined with ultrasound-targeted microbubble activation on VX2 rabbit liver tumors10.7863/jum.2010.29.1.61 ↗
24. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles10.1016/j.biomaterials.2011.07.032 ↗
25. In vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled drug delivery10.1016/j.nano.2010.01.012 ↗
26. Doxorubicin loaded superparamagnetic PLGA-iron oxide multifunctional microbubbles for dual-mode US/MR imaging and therapy of metastasis in lymph nodes10.1016/j.biomaterials.2012.12.003 ↗
27. PLGA/polymeric liposome for targeted drug and gene co-delivery10.1016/j.biomaterials.2010.07.082 ↗
28. Ultrasound-mediated micellar drug delivery10.3109/02656736.2012.665567 ↗
29. Indocyanine green-loaded biodegradable tumor targeting nanoprobes for in vitro and in vivo imaging10.1016/j.biomaterials.2012.04.044 ↗
30. Enhancement of ultrasound contrast agent in high-intensity focused ultrasound ablation10.1007/BF02850207 ↗
31. The use of a micro-bubble agent to enhance rabbit liver destruction using high intensity focused ultrasound10.1016/j.ultsonch.2005.02.001 ↗
32. Use of a microbubble agent to increase the effects of high intensity focused ultrasound on liver tissue10.1007/s00330-005-2663-7 ↗